Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Marts 2020

Planlagt Fastgjort Låst Flyttet Genmab
1.5k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • nohopeN Offline
    nohopeN Offline
    nohope
    wrote on sidst redigeret af
    #83

    Neeeeeej -

    1 Reply Last reply
    0
    • royalR Offline
      royalR Offline
      royal
      wrote on sidst redigeret af
      #84

      Min siger 5,53

      1 Reply Last reply
      0
      • royalR Offline
        royalR Offline
        royal
        wrote on sidst redigeret af
        #85

        Link Preview Image
        Genmab A/S (GMAB) Stock Price, News, Quote & History - Yahoo Finance

        Find the latest Genmab A/S (GMAB) stock quote, history, news and other vital information to help you with your stock trading and investing.

        favicon

        Yahoo Finance (finance.yahoo.com)

        1 Reply Last reply
        0
        • nohopeN Offline
          nohopeN Offline
          nohope
          wrote on sidst redigeret af
          #86

          Jeg burde have skrevet at jeg referede til DJ - beklager

          1 Reply Last reply
          0
          • B Offline
            B Offline
            bikube
            wrote on sidst redigeret af
            #87

            24,04$ Hvad er kursen på $ idag?

            1 Reply Last reply
            0
            • nohopeN Offline
              nohopeN Offline
              nohope
              wrote on sidst redigeret af
              #88

              6,71

              1 Reply Last reply
              0
              • nohopeN Offline
                nohopeN Offline
                nohope
                wrote on sidst redigeret af
                #89

                161,30

                1 Reply Last reply
                0
                • nohopeN Offline
                  nohopeN Offline
                  nohope
                  wrote on sidst redigeret af
                  #90
                  • men det er ikke US der sætter kursen i DK.
                  1 Reply Last reply
                  0
                  • J Offline
                    J Offline
                    Jazzz
                    wrote on sidst redigeret af
                    #91

                    Er der slet
                    ingen der er nervøse for Sanofi godk overhovedet?

                    1 Reply Last reply
                    0
                    • B Offline
                      B Offline
                      bibob
                      wrote on sidst redigeret af
                      #92

                      God morgen. 🙂

                      1 Reply Last reply
                      0
                      • T Offline
                        T Offline
                        transalp
                        wrote on sidst redigeret af
                        #93

                        Go morgen.. 🙂

                        1 Reply Last reply
                        0
                        • Helge_LarsenPI-redaktørH Offline
                          Helge_LarsenPI-redaktørH Offline
                          Helge_LarsenPI-redaktør
                          wrote on sidst redigeret af
                          #94

                          Vincent Rajkumar
                          @VincentRK
                          ·
                          7 t
                          Today @US_FDA
                          @FDAOncology
                          approved isatuximab (Sarclisa) for relapsed refractory myeloma.

                          Im happy that @SanofiUS
                          has priced it significantly lower than daratumumab. I hope there is a price war, & prices drop more. Based on cost, I’ll prefer Isa-PomDex to Dara-PomDex. @mtmdphd

                          1 Reply Last reply
                          0
                          • Helge_LarsenPI-redaktørH Offline
                            Helge_LarsenPI-redaktørH Offline
                            Helge_LarsenPI-redaktør
                            wrote on sidst redigeret af
                            #95

                            Vincent Rajkumar
                            @VincentRK
                            ·
                            7 t
                            I was an author on the isatuximab pivotal trial. Im working with both @sanofi
                            and @JanssenUS
                            on other trials.

                            Look forward to thoughts on how we support the appropriate choice of drug taking cost into account from @Rfonsi1
                            @akeithstewart
                            @peterbachmd
                            & others who are interested

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #96

                              #ACTRIMS2020 – Results of Ofatumumab Self-injection Pen Equivalent to Infusion, APLIOS Trial Shows https://multiplesclerosisnewstoday.com/news-posts/2020/02/28/actrims2020-poster-session-lb300-onset-of-b-cell-depletion-with-subcutaneous-administration-of-ofatumumab-in-relapsing-multiple-sclerosis-results-from-the-aplios-bioequivalence-study

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #97

                                CureVac still in the Coronavirus Vaccine race https://www.globenewswire.com/news-release/2020/03/02/1993888/0/en/CureVac-CEO-Daniel-Menichella-Discusses-Coronavirus-Vaccine-Development-with-U-S-President-Donald-Trump-and-Members-of-Coronavirus-Task-Force.html

                                1 Reply Last reply
                                0
                                • B Offline
                                  B Offline
                                  bibob
                                  wrote on sidst redigeret af
                                  #98

                                  Karyopharm. https://www.statnews.com/2020/03/02/karyopharm-to-seek-expanded-use-of-multiple-myeloma-drug-following-positive-clinical-trial/

                                  1 Reply Last reply
                                  0
                                  • V Offline
                                    V Offline
                                    Vitus
                                    wrote on sidst redigeret af
                                    #99

                                    Tegner til en forrygende åbning 🙂

                                    1 Reply Last reply
                                    0
                                    • L Offline
                                      L Offline
                                      lahn1
                                      wrote on sidst redigeret af
                                      #100

                                      Godt spg, Jazzz 23:14, Er det EQUULEUS vi skal sammenligne med ?

                                      1 Reply Last reply
                                      0
                                      • S Offline
                                        S Offline
                                        Sukkeralf
                                        wrote on sidst redigeret af
                                        #101

                                        Det største problem med Sanofi er, at pt sælger Genmab mest med Daratumumab i kombination med POM-DEX, så det er lidt samme patientgrundlag. Tilsyneladende er denne kombi ogås meget brugt i anden linie, så spørgsmålet er om Sanofi også kan vinde indpas der med en lavere prissætning. Lad os håbe at sc dosering er en game changer som Jan siger - omvendt kan Sanofi indpas gøre det svært for JNJ at hæve prisen pt.

                                        1 Reply Last reply
                                        0
                                        • S Offline
                                          S Offline
                                          Sukkeralf
                                          wrote on sidst redigeret af
                                          #102

                                          Karyopharm henter penge igen

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger